Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
09/1996
09/18/1996CN1131153A 1-oxy-2-(phenylsulfonamido-) amyl piperidine derivant, its preparation method and medicinal use thereof
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556942 Glutathione S-transferase-activated compounds
09/17/1996US5556609 Metal labled peptides for medical diagnosis of diseases
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027370A1 Free radical scavenger molecules
09/12/1996WO1996016079A3 Alpha-ketoamide derivatives as cathepsin l inhibitor
09/11/1996EP0731110A1 Methods for the production of conformationally stabilized cell adhesion peptides
09/11/1996EP0731107A1 Production of aldehyde derivatives
09/11/1996EP0731106A1 Novel peptide derivative
09/11/1996EP0731088A2 Retroviral protease inhibitors
09/11/1996EP0730605A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
09/11/1996EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
09/11/1996EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
09/11/1996EP0730469A1 Modified truncated complement system regulators
09/11/1996EP0730467A1 Inhibitors of farnesyl-protein transferase
09/11/1996EP0730454A1 Antiarrhythmic benzodiazepines
09/11/1996CN1130898A Difluoro statone antiviral analogs
09/10/1996US5554783 (2r, 3r, 4s, 5s)-3-acetoxy-2,5-bis/benzyloxycarbonylamino/ -4-bromo-1,5-diphenylhexane
09/10/1996US5554756 Amino acid derivatives
09/10/1996US5554728 Lipid conjugates of therapeutic peptides and protease inhibitors
09/10/1996US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
09/10/1996US5554644 Tachykinin (NK2) antagonists
09/10/1996US5554643 Pro-drugs for CCK antagonists
09/10/1996US5554641 Nonpeptides as tachykinin antagonists
09/10/1996US5554594 Imidazolidine derivatives
09/10/1996US5554375 Hair growth
09/06/1996WO1996027019A1 Transgenic animals as model of psoriasis
09/06/1996WO1996026956A1 Protein phosphatase inhibitor
09/06/1996WO1996026955A1 Peptide and a method of obtaining it
09/06/1996WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
09/06/1996WO1996022305A3 Modified peptides
09/06/1996WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996WO1996012729A3 Method for peptide synthesis based on n-(n'-nitrosocarbamoyl)amino acids
09/06/1996CA2213669A1 Transgenic animals as model of psoriasis
09/06/1996CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
09/04/1996EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use
09/04/1996EP0644181B1 Amino acid derivative and use thereof
09/04/1996CN1130385A Antibiotics 10381V. W. X. Y. Z1, Z2 Pre-B and T
09/04/1996CN1130192A Crystallizing method for alpha-L-aspartyl-L-phenyl methyl lactamine from water solution
09/03/1996US5552558 Retroviral protease inhibiting compounds
09/03/1996US5552525 Radiodiagnostic reagents using peptides for detection of infections
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552400 Inhibitors of protease activity
09/03/1996US5552397 Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
09/03/1996US5552385 Pharmaceutical formulation
08/1996
08/29/1996WO1996026213A1 Method of producing l-aspartyl-d-alanine-n-(thiethane-3-yl)-amides
08/29/1996DE19506669A1 Lipoxygenase inhibitor for treating asthma, tumours, shock etc.
08/29/1996DE19506610A1 New orally active thrombin inhibiting peptide cpds.
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728196A1 Mutants of a thermostable neutral protease from bacillus
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0717736A4 Polar-substituted hydrocarbons
08/28/1996EP0621862B1 Organic salts of n, n'-diacetyl cystine
08/28/1996CN1129705A A method of preparing L-aspartyl-D-alpha-aminoalkanecarboxylic acid -(S)-N-alpha-alkylbenzylamide
08/27/1996US5550316 Transgenic animal model system for human cutaneous melanoma
08/27/1996US5550283 Chemical intermediates for alanylglutamine
08/27/1996US5550262 Treatment of muscles wasting diseases
08/27/1996US5550183 Metal-peptide compositions and methods for stimulating hair growth
08/27/1996US5550159 Peptide mimics useful as platelet aggregation inhibitors
08/27/1996US5550131 2-piperazinone compounds and their use
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/22/1996WO1996025428A1 Novel nk374186 analogues or pharmacologically acceptable salts thereof
08/22/1996WO1996025427A1 Serine protease inhibitors
08/22/1996WO1996025426A1 Novel dipeptide amidines as thrombin inhibitors
08/22/1996DE19505933A1 Verfahren zur Herstellung von L-Aspartyl-D-alanin-N-(thietan-3-yl)-amiden A process for preparing amides of L-aspartyl-D-alanine-N- (thietane-3-yl)
08/22/1996CA2212830A1 Serine protease inhibitors
08/22/1996CA2211109A1 Novel thrombin inhibitors
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0726936A1 Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme
08/21/1996EP0726909A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0589949B1 New peptides (didemnins), their preparation and their use
08/21/1996EP0478729B1 Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor
08/20/1996US5547666 Antibiotic GE 2270 factors A1, A2, A3 and H
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/15/1996WO1996024849A1 Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024617A1 Desaminononapeptides, process for preparing the same and their use for preparing elcatonin
08/15/1996WO1996024616A1 PROCESS FOR PREPARING CALCITONIN AND L-α-AMINOSUBERIC ACID DERIVATIVES BY ENZYMATIC CONDENSATION
08/15/1996WO1996024612A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024611A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024610A1 BRANCHED TRIPEPTIDE COMBINATORIAL LIBRARIES AND USE IN uPA MEDIATED DISORDERS
08/15/1996WO1996024609A1 Thrombin inhibitors
08/15/1996WO1996024608A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996WO1996024607A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212669A1 Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
08/15/1996CA2212437A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212372A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/15/1996CA2210989A1 Thrombin inhibitors
08/15/1996CA2210955A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996CA2210953A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/14/1996EP0725790A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
08/14/1996EP0725788A1 2'-amido and 2'-peptido modified oligonucleotides
08/14/1996EP0725650A1 Inhibitors of farnesyl-protein transferase
08/14/1996EP0641333B1 Method for making intermediates useful in synthesis of retroviral protease inhibitors